title: Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma.
authors.affiliation: Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. rinib2@ccf.org
authors.forename: Brian I
authors.initials: BI
authors.lastname: Rini
authors.forename: Mark
authors.initials: M
authors.lastname: Stein
authors.forename: Pat
authors.initials: P
authors.lastname: Shannon
authors.forename: Simantini
authors.initials: S
authors.lastname: Eddy
authors.forename: Allison
authors.initials: A
authors.lastname: Tyler
authors.forename: Joe J
authors.initials: JJ
authors.lastname: Stephenson
authors.forename: Lorie
authors.initials: L
authors.lastname: Catlett
authors.forename: Bo
authors.initials: B
authors.lastname: Huang
authors.forename: Diane
authors.initials: D
authors.lastname: Healey
authors.forename: Michael
authors.initials: M
authors.lastname: Gordon